Barrett's Metaplasia Progression towards Esophageal Adenocarcinoma: An Attempt to Select a Panel of Molecular Sensors and to Reflect Clinical Alterations by Experimental Models.

Adenocarcinoma / pathology Barrett Esophagus / metabolism Esophageal Neoplasms / pathology Gastroesophageal Reflux / genetics Humans Metaplasia Models, Theoretical SOXC Transcription Factors
Barrett’s esophagus bile acids cancer transformation esophageal adenocarcinoma gastroesophageal reflux disease translational model

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
18 Mar 2022
Historique:
received: 03 01 2022
revised: 14 03 2022
accepted: 15 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 9 4 2022
Statut: epublish

Résumé

The molecular processes that predispose the development of Barrett's esophagus (BE) towards esophageal adenocarcinoma (EAC) induced by gastrointestinal reflux disease (GERD) are still under investigation. In this study, based on a scientific literature screening and an analysis of clinical datasets, we selected a panel of 20 genes covering BE- and EAC-specific molecular markers (

Identifiants

DOI: 10.3390/ijms23063312 PMID: 35328735 PMC: PMC8955539
pubmed: 35328735
pii: ijms23063312
doi: 10.3390/ijms23063312
pmc: PMC8955539
pii:
doi:

Substances chimiques

SOX4 protein, human 0
SOXC Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Science Center
ID : UMO-2016/23/D/NZ4/01913
Organisme : The National Centre for Research and Development, Poland
ID : LIDER/9/0055/L-8/16/NCBR/2017

Références

Cancer Sci. 2017 Feb;108(2):178-186
pubmed: 27865045
J Mol Histol. 2011 Apr;42(2):137-51
pubmed: 21360047
Int J Cancer. 2008 Mar 15;122(6):1303-10
pubmed: 18000824
Gut. 2018 Mar;67(3):430-440
pubmed: 28232473
Cancers (Basel). 2020 Aug 04;12(8):
pubmed: 32759723
J Physiol Pharmacol. 2005 Sep;56 Suppl 5:33-55
pubmed: 16247188
Lancet. 2018 Aug 4;392(10145):400-408
pubmed: 30057104
Dis Esophagus. 2003;16(3):177-86
pubmed: 14641306
Sci Rep. 2020 Mar 17;10(1):4899
pubmed: 32184470
Am J Physiol Gastrointest Liver Physiol. 2012 Dec 15;303(12):G1335-46
pubmed: 23064761
Digestion. 2017;95(4):253-261
pubmed: 28384630
Nat Genet. 2013 May;45(5):478-86
pubmed: 23525077
Genes Chromosomes Cancer. 2013 Dec;52(12):1123-32
pubmed: 24123713
J Exp Clin Cancer Res. 2019 Jan 9;38(1):13
pubmed: 30626422
Int J Mol Sci. 2020 Sep 03;21(17):
pubmed: 32899384
Mol Cytogenet. 2012 Nov 29;5(1):43
pubmed: 23194200
Am J Physiol Gastrointest Liver Physiol. 2011 Aug;301(2):G278-86
pubmed: 21636532
Aging (Albany NY). 2020 Mar 12;12(5):4603-4616
pubmed: 32165590
Surg Endosc. 2019 Sep;33(9):2901-2908
pubmed: 30456503
Oncologist. 2018 Nov;23(11):1319-1327
pubmed: 29866946
Oncogene. 2020 Jan;39(4):877-890
pubmed: 31570787
Cells. 2020 May 12;9(5):
pubmed: 32408627
Gastroenterol Clin North Am. 2016 Sep;45(3):399-412
pubmed: 27546839
Curr Pharm Des. 2011;17(16):1541-51
pubmed: 21548865
Sci Rep. 2021 Mar 23;11(1):6664
pubmed: 33758229
Therap Adv Gastroenterol. 2012 Sep;5(5):285-99
pubmed: 22973415
Cancer Cell. 2008 Nov 4;14(5):408-19
pubmed: 18977329
Pathobiology. 2017;84(2):87-98
pubmed: 27656900
Nat Protoc. 2012 Jan 12;7(2):235-46
pubmed: 22240585
Cancer Cell. 2012 Jan 17;21(1):36-51
pubmed: 22264787
Mutat Res. 2005 Jan;589(1):47-65
pubmed: 15652226
Nat Rev Dis Primers. 2017 Jul 27;3:17048
pubmed: 28748917
Int J Cancer. 2009 Nov 15;125(10):2349-59
pubmed: 19670330
J Cell Physiol. 2017 Dec;232(12):3221-3225
pubmed: 28092101
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Biochem Soc Trans. 2010 Apr;38(2):348-52
pubmed: 20298181
World J Surg Oncol. 2018 Jun 19;16(1):114
pubmed: 29921304
Am J Surg Pathol. 2016 May;40(5):e45-66
pubmed: 26813745
Pathol Res Pract. 2012 May 15;208(5):269-80
pubmed: 22541897
Histopathology. 2011 Mar;58(4):531-42
pubmed: 21371075
Cancer Cell. 2018 Apr 9;33(4):721-735.e8
pubmed: 29622466
J Gastrointest Surg. 2013 Nov 15;:
pubmed: 24234242
Cell Signal. 2018 Nov;51:222-232
pubmed: 30102978
Br J Cancer. 1997;75(2):258-63
pubmed: 9010035
Am J Epidemiol. 2007 Jun 15;165(12):1424-33
pubmed: 17420181
Physiology (Bethesda). 2017 Jul;32(4):266-277
pubmed: 28615311
Folia Histochem Cytobiol. 2012 Apr 24;50(1):12-9
pubmed: 22532131
BMC Gastroenterol. 2009 Jul 23;9:59
pubmed: 19627616
Scand J Gastroenterol Suppl. 2006;(243):11-7
pubmed: 16782617
Oncoscience. 2014 Jun 02;1(5):326-35
pubmed: 25594027
Cancer Res. 2009 Dec 1;69(23):9083-9
pubmed: 19920191
Lab Invest. 2008 Jun;88(6):643-51
pubmed: 18427553
Histopathology. 2003 May;42(5):457-65
pubmed: 12713622
Cell Cycle. 2012 Dec 1;11(23):4328-38
pubmed: 23095673
PLoS One. 2013 Oct 11;8(10):e76667
pubmed: 24146905
Ann N Y Acad Sci. 2013 Oct;1300:187-199
pubmed: 24117642
Clin Transl Oncol. 2016 Jan;18(1):65-72
pubmed: 26250764
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):582-597
pubmed: 32246941
Cancer Res. 2008 Feb 15;68(4):1136-43
pubmed: 18281489
Dis Esophagus. 2007;20(3):256-64
pubmed: 17509124
J Physiol Pharmacol. 2010 Aug;61(4):409-18
pubmed: 20814068
Semin Cancer Biol. 2020 Dec;67(Pt 1):57-64
pubmed: 31445218
JAMA Oncol. 2019 Dec 1;5(12):1749-1768
pubmed: 31560378
Future Oncol. 2020 Sep;16(25):1903-1909
pubmed: 32449621
Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):3-16
pubmed: 25743452
Cell Mol Gastroenterol Hepatol. 2018 Jan 31;5(4):461-478
pubmed: 29713660
Carcinogenesis. 2021 Aug 19;42(8):1068-1078
pubmed: 33878160
Biosci Rep. 2019 Aug 13;39(8):
pubmed: 31345960
Gastroenterology. 2018 Jan;154(2):267-276
pubmed: 28780072
Cancer Res. 2016 Sep 1;76(17):4994-5005
pubmed: 27328729
Mol Cancer. 2015 Feb 03;14:24
pubmed: 25644061
Z Gastroenterol. 2012 Sep;50(9):1028-34
pubmed: 22965634
Semin Cancer Biol. 2020 Dec;67(Pt 1):122-153
pubmed: 30914279
Gut. 2013 Oct;62(10):1406-14
pubmed: 22917659
Cancers (Basel). 2021 Nov 27;13(23):
pubmed: 34885081
Front Genet. 2021 Jul 05;12:635429
pubmed: 34290732
Scand J Immunol. 2018 Dec;88(6):e12727
pubmed: 30341772
BMC Gastroenterol. 2019 Mar 6;19(1):38
pubmed: 30841855
J Physiol Pharmacol. 2005 Sep;56 Suppl 5:57-73
pubmed: 16247189
Annu Rev Med. 2017 Jan 14;68:213-227
pubmed: 27618753
Cancer Res. 2005 Apr 15;65(8):3146-54
pubmed: 15833844
Inflammopharmacology. 2007 Jun;15(3):95-100
pubmed: 19847948
N Engl J Med. 2011 Oct 13;365(15):1375-83
pubmed: 21995385
Gastroenterology. 2019 Jan;156(1):130-144.e10
pubmed: 30268789
J Cell Physiol. 2012 Jun;227(6):2654-9
pubmed: 21882191
J Biol Chem. 2010 Nov 19;285(47):36804-17
pubmed: 20829348
Cell Oncol (Dordr). 2012 Jun;35(3):149-61
pubmed: 22476962
JAMA. 2013 Aug 14;310(6):627-36
pubmed: 23942681
Cancer Cell. 2011 Apr 12;19(4):456-69
pubmed: 21481788
Eur J Cancer Prev. 2016 Sep;25(5):368-79
pubmed: 26378497
World J Gastroenterol. 2019 Jan 14;25(2):233-244
pubmed: 30670912
J Comput Biol. 2019 Dec;26(12):1367-1378
pubmed: 31259619
Ann Cardiothorac Surg. 2017 Mar;6(2):99-109
pubmed: 28446998
Radiographics. 2014 Oct;34(6):1722-40
pubmed: 25310426
Pancreatology. 2020 Oct;20(7):1479-1485
pubmed: 32948431
Int J Cancer. 2011 Jan 15;128(2):274-82
pubmed: 20309934
Oral Oncol. 2010 Feb;46(2):123-7
pubmed: 20036603

Auteurs

Edyta Korbut (E)

Cellular Engineering and Isotope Diagnostics Laboratory, Department of Physiology, Jagiellonian University Medical College, 16 Grzegorzecka Street, 31-531 Cracow, Poland.
ORCID: 0000-0003-0750-5389

Kinga Krukowska (K)

Cellular Engineering and Isotope Diagnostics Laboratory, Department of Physiology, Jagiellonian University Medical College, 16 Grzegorzecka Street, 31-531 Cracow, Poland.
ORCID: 0000-0001-7424-9851

Marcin Magierowski (M)

Cellular Engineering and Isotope Diagnostics Laboratory, Department of Physiology, Jagiellonian University Medical College, 16 Grzegorzecka Street, 31-531 Cracow, Poland.
ORCID: 0000-0003-0175-5600

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs épithéliales épidermoïdes et glandulaires › Carcinomes › Adénocarcinome › Barrett's Metaplasia Progression towards...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies gastro-intestinales › Maladies de l'oesophage › Oesophage de Barrett › Barrett's Metaplasia Progression towards...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies gastro-intestinales › Tumeurs gastro-intestinales › Tumeurs de l'oesophage › Barrett's Metaplasia Progression towards...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies gastro-intestinales › Maladies de l'oesophage › Dyskinésies oesophagiennes › Reflux gastro-oesophagien › Barrett's Metaplasia Progression towards...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Barrett's Metaplasia Progression towards...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Métaplasie › Barrett's Metaplasia Progression towards...
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Barrett's Metaplasia Progression towards...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › Facteurs de transcription SOX › Facteurs de transcription SOX-C › Barrett's Metaplasia Progression towards...